GlassScriptPhysician profile
Jean Cheng
NPI 1740331636
$4,437.30
in general payments reported to CMS, 2019-2025
15 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $491 · 2021: $1,069 · 2022: $489 · 2023: $652 · 2024: $719 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894 · Entertainment: $14.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.52 |
| Entertainment | $14.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $973.49 | 2019-2021 | |
| Horizon Therapeutics Plc | $710.64 | 2021-2023 | Tepezza |
| Amgen INC. | $660.76 | 2024-2025 | Tepezza |
| Dompe US, INC. | $485.45 | 2021-2022 | |
| Alcon Vision LLC | $419.31 | 2022-2025 | Clareon, Rocklatan, Tryptyr |
| Sun Pharmaceutical Industries INC. | $293.16 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $262.25 | 2023-2025 | Xiidra, Miebo |
| Shire North American Group INC | $150.05 | 2019 | |
| Abbvie INC. | $145.39 | 2023-2025 | Lumigan |
| Allergan, INC. | $139.64 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $116.17 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $30.78 | 2025 | Acthar |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $16.57 | 2022 | |
| Optos, INC. | $14.24 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.